On January 30, GLONGHUI | Robust Healthcare (300888.SZ) announced that net profit is expected to be 68,000.00 to 800,000 yuan in 2023, down 51.53% to 58.80% year on year, after deducting 51,000.00 to 60.000 million yuan in non-net profit, down 61.56% to 67.33% year on year.
In 2023, the company achieved cumulative operating revenue of 8.06 billion yuan to 8.26 billion yuan, a year-on-year decrease of 27.23% to 29.00%. <放弃房地产权利声明书>Due to the fact that the company and Shenzhen Xingda Real Estate Development Co., Ltd. (hereinafter referred to as “Xingda Company”) signed the “Confirmation on Withdrawal” on January 29, 2024, there was a new situation where progress on the project was suspended. Based on the principle of prudence, the company decided to recover the confirmed asset disposal proceeds for the Q3 quarter of 2023, totaling 1.36 billion yuan in net profit. In 2023, the company handled inventory of infection protection products (including masks, protective clothing, isolation gowns, etc.) and scrapped infection protection products and equipment, reducing profits by about 250 million yuan.